News
9d
News-Medical.Net on MSNElectromagnetic waves disrupt SARS-CoV-2 spike protein and lower infectivityResearchers demonstrated that specific electromagnetic wave frequencies can disrupt the SARS-CoV-2 Spike protein structure in ...
In a first, the study published in the journal Emerging Microbes and Infections demonstrated the team’s patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya ...
In a study published Aug. 9 in the journal Science, the researchers used genetic engineering to create a version of HIV called a therapeutic interfering particle (TIP). This virus-like particle is ...
A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. By 2030, the World Health Organization (WHO), the Global Fund and ...
The formation of VLP is depicted in Figure 1. Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has ...
Researchers at CIDR, led by Yuntao Wu, professor in George Mason's School of Systems Biology and the principal investigator of the study, developed a special HIV-like virus particle, called HIV ...
Electron microscope magnified virus like particles in panels A and B that are used in the vaccine. These are similar in appearance to the actual Zika virus magnified in panel E. Monoclonal ...
Stranger still, we found that PEG10 behaves like a virus, too. It can form a virus-like particle, and it cleaves itself into smaller pieces like some viruses do. We found that one of those pieces ...
that compared the safety and immunogenicity of a single intramuscular dose of Vimkunya (n=2559), a virus-like particle chikungunya vaccine, with placebo (n=424) in healthy participants 12 to 64 ...
The virus-like particle-based vaccine, dubbed HIL-214, missed all primary and secondary endpoints of the NEST-IN1 study of more than 2,800 infants aged about five months of age in the U.S. and ...
Hovione and Firstgene enter strategic collaboration to advance virus-like particle platform for liver cancer: Lisbon, Portugal Thursday, May 15, 2025, 13:00 Hrs [IST] Hovione, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results